Atypical manifestation of cutaneous lupus erythematosus in Human Immunodeficiency Virus infection patient: A case report

Jatakul  Kietkhongnatee; Voraphol Vejjabhinanta; Poonnawis  Sudtikoonnaseth; Praneet  Sajjachareonpong

Authors

Jatakul Kietkhongnatee Institute of Dermatology, Department of Medical Services, Ministry of Public Health
Voraphol Vejjabhinanta Southern Regional Hospital of Tropical Dermatology-Trang Province, Department of Medical Services, Ministry of Public Health
Poonnawis Sudtikoonnaseth Institute of Dermatology, Department of Medical Services, Ministry of Public Health
Praneet Sajjachareonpong Institute of Dermatology, Department of Medical Services, Ministry of Public Health

Keywords:

Cutaneous lupus erythematosus, Atypical manifestration, Human Immunodeficiency Virus, coexistence, HIV infection

Abstract

Abstract

Cutaneous lupus erythematosus (CLE) and Human Immunodeficiency Virus (HIV) infection are caused by the opposite effect of the immune response, increased immune activity in CLE, and decreased activity in HIV infection. CLE is an immune complex-mediated autoimmune disorder that interacts with multifactorial causes. CLE has three different presentation types: acute, subacute, and chronic; each type has a typical and atypical presentation, while HIV infection is an immunodeficiency disorder caused by a virus that affects T-lymphocyte CD4+ cells. We report a case of an atypical rash of CLE in a male with HIV infection. The pathogenetic implications of this coexistence of CLE and HIV are discussed. Furthermore, the treatment is very challenging.

Keywords

Cutaneous lupus erythematosus, Atypical manifestration, Human Immunodeficiency Virus, coexistence, HIV infection

References

Kalden JR, Winkler TH, Herrmann M, Krapf F. Pathogenesis of SLE: immunopathology in man. Rheumatol Int. 1991;11(3):95-100.

Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann Intern Med. 2020;172(11):ITC81-96.

Pyfrom S, Paneru B, Knox JJ, Cancro MP, Posso S, Buckner JH, et al. The dynamic epigenetic regulation of the inactive X chromosome in heathy human B cell is dysregulated in lupus patients. Proc Natl Acad Sci USA. 2021;118(24):e2024624118.

Tsokos GC. Mechanism of disease systemic lupus erythematosus. N Engl j Med. 2011;365:2110-21.

Pan L, Lu M-P, Wang J-H, Xu M, Yang S-R. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr.2020;16(1):19-30.

Yu B, Qi Y, Li R, Shi Q, Satpathy AT, Chang HY. B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells. Cell. 202;184(7):1790-180.e17.

Zucchi D, Elefante E, Schiliro D, Signorini V, Tretin F, Bortoluzzi A, et al. One year in review 2022: systemic lupus erythematosus. Clin Exp Rheumatol. 2022;40(1):4-14.

Herzum A, Gasparini G, Cozzani E, Burlando M, Parodi A, Atypical and rare form of cutaneous lupus erythematosus: The importance of the diagnosis for the best management of patients. Dermatology.2021;238(2):195-204.

Gallo RC, Garzino-Demo A, DeVICO AL. HIV infection and pathogenesis: What About Chemokines? J Clin Immunol. 1999;19(5):293-9.

Yen YF, Chuang PH, Jen IA, Chen M, Lan YC, et al. Incidence of autoimmune disease in a nationwide HIV/AIDS patient cohort in Taiwan, 2000-2012. Ann Rheum Dis. 2017;76(4):661-5.

Fox RA, Isenberg DA. Human immunodeficiency virus infection in systemic lupus erythematosus. Arthritis Rheum. 1997;40(6):1168-72.

Goddard GZ, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev. 2002;1(6):329-37.

Abbot IJ, Chand CC, Skinner MJ, Street A, Perry G, et al. Development and management of systemic lupus erythematosus in an HIV-infected man with hepatitis C and B co-infection following interferon therapy: a case report. J Med Case Rep. 2009;3:7289.

Carugati M, Franzetti M, Torre A, Giorgi R, Genderini A, et al. Systemic lupus erythematosus and HIV infection; a whimsical relationship. Reports of two cases and review of the literature. Clin Rheumatol. 2013;32(9):1399-405.

Calza L, Manfredi R, Colangeli V, D’Antuono A, et al. Systemic and discoid lupus erythematosus in HIV-infection patients treated with highly active antiretroviral therapy. Int J STD AIDS. 2003;14(5):356-9.

Chamberlain AJ, Hollowood K, Turner RJ, Byren I. Tumid lupus erythematosus occurring following highly active antiretroviral therapy for HIV infection: A manifestation of immune restoration. J Am Dermatol. 2004;51:S161-5.

Liao HY, Tao CM, Su J. Concomitant systemic lupus erythematosus and HIV infection: A rare case report and literature review. Medicine. 2017;96(51):e9337.